Skip to main content
Signal8
Launch Terminal
Bell Margaret Smith profile photo

Margaret Smith Bell

CIK: 0001716713

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Tonix Pharmaceuticals Holding Corp. logo
TNXP

Tonix Pharmaceuticals Holding Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Tonix Pharmaceuticals Holding Corp. logo
    TNXP

    Tonix Pharmaceuticals Holding Corp.

    May 12, 2026
    Award(A)

    Stock Option

    Direct
    22.7K shares-
  • Tonix Pharmaceuticals Holding Corp. logo
    TNXP

    Tonix Pharmaceuticals Holding Corp.

    May 13, 2025
    Award(A)

    Stock Option

    Direct
    10K shares-
  • Tonix Pharmaceuticals Holding Corp. logo
    TNXP

    Tonix Pharmaceuticals Holding Corp.

    Feb 5, 2025
    Other(J)
    Direct
    1 shares at avg. $0.15$0.15

1-3 of 3

About Bell Margaret Smith

Bell Margaret Smith (SEC CIK 0001716713) files insider reports with the SEC as Director of Tonix Pharmaceuticals Holding Corp. (TNXP).

Signal8 holds 3 ownership filings by Bell Margaret Smith, all Form 4s, filed between Feb 28, 2025 and May 14, 2026. Those filings report 3 transactions, from Feb 5, 2025 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bell Margaret Smith's filings is in BERKELEY HEIGHTS, NJ.

Recent filings by Bell Margaret Smith

  • May 12, 2026: Grant or award of TNXP derivative securities (Form 4, code A).
  • May 13, 2025: Grant or award of TNXP derivative securities (Form 4, code A).
  • Feb 5, 2025: Other transaction of TNXP shares (Form 4, code J).

Other insiders filing for Tonix Pharmaceuticals Holding Corp. (TNXP)

How to read Form 4 transaction codes